Submission Details
| 510(k) Number | K023312 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 03, 2002 |
| Decision Date | November 01, 2002 |
| Days to Decision | 29 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K023312 is an FDA 510(k) clearance for the CONTROL PLASMA P, a Control, Plasma, Abnormal (Class II — Special Controls, product code GGC), submitted by Dade Behring, Inc. (Newark, US). The FDA issued a Cleared decision on November 1, 2002, 29 days after receiving the submission on October 3, 2002. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5425.
| 510(k) Number | K023312 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 03, 2002 |
| Decision Date | November 01, 2002 |
| Days to Decision | 29 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GGC — Control, Plasma, Abnormal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.5425 |